Search Results - "Pottackal, Ginto"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective by Liu, Tao, Neuner, Rosemarie, Thompson, Aliza, Pottackal, Ginto, Petullo, David, Liu, Jiang, Nikolov, Nikolay, Sahajwalla, Chandrahas, Doddapaneni, Suresh, Chen, Jianmeng

    Published in Lupus (01-04-2022)
    “…On 16 December 2020, FDA approved Benlysta® (belimumab) for both the intravenous (IV) and subcutaneous (SC) administration routes for the treatment of adult…”
    Get full text
    Journal Article
  2. 2

    On the Assessment of Average Biosimilarity Based on a Three-Arm Parallel Design by Pottackal, Ginto Jacob, Mathew, Thomas

    “…Average biosimilarity is investigated under a three-arm parallel design: one arm corresponds to the test drug T, and the other two arms correspond to two…”
    Get full text
    Journal Article
  3. 3

    Some Tests, Confidence Limits and Tolerance Limits for Assessing Biosimilarity by Pottackal, Ginto

    Published 01-01-2015
    “…Biosimilars or follow-on biologics are defined as biological medicinal products that are expected to be similar to a licensed biological product. The standard…”
    Get full text
    Dissertation